Trials / Recruiting
RecruitingNCT06272279
Neuromodulation With Spinal Stimulation Methods
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot research study to test the protocols needed for transcutaneous spinal electrical stimulation in persons living with spinal cord injury (SCI). Up to 24 participants will be enrolled. A variety of stimulation parameters and outcome measures will be assessed.
Detailed description
Purpose of this project Spinal cord stimulation has the potential to improve motor function recovery after spinal cord injury. Commonly used approaches include low-intensity, direct current (DC) stimulation applied across multiple segments, electrical transcutaneous (ETC) stimulation, and magnetic transcutaneous stimulation (MTC). Objective: to evaluate and compare the voluntary and reflexive motor performance in the same subjects, including people with and without spinal cord injury, after non-invasive spinal cord stimulation interventions. Comparing two different interventions applied in different experimental sessions and the respective sham stimulation is the goal of this study. corticospinal and spinal motor pathways in paraplegics and in non-injured humans will be tested.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | spinal stimulation-DCS | transcutaneous spinal stimulation by direct current stimulation |
| OTHER | spinal stimulation-sham DCS | sham transcutaneous spinal stimulation by direct current stimulation |
| OTHER | spinal stimulation-EPS | transcutaneous spinal stimulation by electrical pulsed stimulation |
| OTHER | sham spinal stimulation-EPS | sham transcutaneous spinal stimulation by electrical pulsed stimulation |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2026-01-31
- Completion
- 2026-02-15
- First posted
- 2024-02-22
- Last updated
- 2025-02-10
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06272279. Inclusion in this directory is not an endorsement.